Clinical Trial Update: Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4) [Phase 4]

View source ↗

Summary

Phase 4 trial for Quadriderme® in impetiginous eczema was terminated; results posted in 2011. The document summarizes safety and efficacy data from a post-appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Dermatitis Atopic
• Eczema Atopic
• Skin Diseases Eczematous

Drugs mentioned

• Quadriderme®

Snippet

Sponsor: Organon and Co | Conditions: Dermatitis, Atopic, Eczema, Atopic | Phase 4 | Status: TERMINATED | Results posted: 2011-06-16